Refine by
Drug Designation Suppliers & Manufacturers
115 companies found
based in, NEW YORK (USA)
CD ComputaBio was established to resolve problems occurring in computational biology. We assembled a team of professionals to collaborate with researchers worldwide, meet our customers' needs, and ensure service quality. We hope to hear from you and ...
based inVilligen, SWITZERLAND
leadXpro specializes in structure-based drug discovery for membrane proteins. leadXpro is a team of experts in membrane protein science. We have an integrated platform for membrane protein biochemistry, biophysics and structural biology, including ...
based inSan Carlos, CALIFORNIA (USA)
Alkahest is a clinical stage biopharmaceutical company targeting neurodegenerative and age-related diseases with transformative therapies derived from a deep understanding of the plasma proteome in aging and ...
One the key chronokine targets identified using Alkahest’s platform is eotaxin. Eotaxin is an immunomodulatory chemokine that is increased in normal aging as well as multiple diseases of aging. It has been implicated in Alzheimer’s ...
based inAustin, TEXAS (USA)
Headquartered in Austin, Texas, Lung Therapeutics, Inc. is a clinical stage biopharmaceutical company formed to leverage decades of leading research in orphan, pulmonary indications for which there are unmet medical needs. The company is developing ...
A pleural effusion is defined by the build-up of fluid in the pleural cavity, predominantly resulting from pneumonia. A loculated pleural effusion (LPE) occurs when scar tissue forms in the pleural cavity, trapping the fluid and preventing ...
based inGoettingen, GERMANY
We provide the essential products, technologies and expertise to produce biopharmaceuticals reliably and efficiently. In fact, Sartorius has been pioneering and setting the standards for single-use products that are currently used throughout all ...
Innovation is at the heart of everything we do. Our proprietary drug delivery technology platform, Veltis®, uses engineered recombinant albumin to enhance albumin’s intrinsic characteristics for optimal therapeutic performance of your ...
based inAlpharetta, GEORGIA (US) (USA)
Clearside Biomedical is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®). The platform provides an in-office, repeatable, non-surgical procedure, offering targeted ...
based inArlington, VIRGINIA (USA)
Your company’s sustainability is our business. With compliance and sustainability measures acting together as a more significant influence on your entire operations-product-chemical management, we believe your intelligence partner should do the ...
based inCalgary, ALBERTA (CANADA)
We are a Calgary, Alberta, Canada based Health, Environment, Safety and Security Consulting company operating in the Oil and Gas, Power Transmission, Mining and Safety Training typically representing the owning companies or EPCM ...
The need to prevent impaired persons from affecting safety in the workplace cannot be overstated. Recent changes in Occupational Health and Safety (OH&S) Legislation, together with better informed employers, has brought forth a realization that ...
based inPoway, CALIFORNIA (USA)
Alfa Scientific Designs, Inc. is a California-licensed, cGMP compliant, and ISO 13485 registered manufacturer of in-vitro diagnostic devices. Founded in 1996, ALFA is a leader in the industry in developing and manufacturing high quality rapid ...
ALFA’s reliability for speed and accuracy in point of care rapid tests is readily available in the configuration you need. Our Multi-Drug Urine Cassette Test formats vary to our customers’ ...
based inCarlton, AUSTRALIA
Radiopharm Theranostics has the ambition to become a recognised leader in the development of radiopharmaceutical products for both diagnostic and therapeutic uses in areas of high unmet medical needs. There is unique potential of ...
DUNP19 is the invention of Professor Ulmert at UCLA. ...
based inVilligen, SWITZERLAND
InterAx combines machine learning, mathematical modeling of cellular processes, and experimental methods derived from more than 10 years of fundamental research to generate high-efficacy leads for a given GPCR target. We decipher drug effects on ...
based inStanmore, UNITED KINGDOM
Acellera’s mission is to accelerate the transition to rational, computerized drug discovery via simulations and machine learning. In order to fulfill this vision, we work with our customers by becoming a key technology partner, boosting their ...
based inParkville, AUSTRALIA
PolyActiva is an innovative clinical-stage ophthalmology company with a unique proprietary polymeric prodrug technology that enables site-specific, precise and controlled drug delivery to the eye. Our mission is to become a leader in ophthalmic ...
based inGeneva, SWITZERLAND
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available, small molecule drugs known as allosteric modulators for neurological disorders. Allosteric ...
Dipraglurant is a novel orally available highly selective metabotropic glutamate receptor subtype 5 negative allosteric modulator (mGlu5 NAM) which has completed Phase 1 and demonstrated efficacy in a Phase 2a proof of concept study for the ...
based inWayne, PENNSYLVANIA (USA)
Palvella Therapeutics was founded to serve individuals suffering from rare diseases by developing safe and efficacious therapies that will dramatically enhance their quality of life. We focus on developing therapies that specifically target the root ...
QTORINTM rapamycin 3.9% is a novel topical therapy being studied for Pachyonychia Congenita (PC). We are currently enrolling our phase 3 study in ...
based inMonterey, CALIFORNIA (USA)
Vybion has pioneered vectorized Intrabodies, the delivery of functional antibody fragments in the scFv format to cells using Adeno associated virus (AAV). The Company has Orphan Drug Designation from the FDA for INT41 to treat Huntington’s disease a ...
INT41 has received Orphan Drug Designation from the FDA for Huntington’s disease. IND enabling studies for INT41 Gene Therapy for Huntington’s disease are in place following a preIND meeting with the FDA ...
based inBozeman, MONTANA (USA)
Montana Molecular specializes in the development of fluorescent biosensors and reporters designed to facilitate drug discovery and research within living cells. With a focus on generating innovative solutions, the company provides tools that allow ...
The Borealis Arrestin Biosensors by Montana Molecular represent a cutting-edge tool in the realm of GPCR drug discovery, focusing on arrestin recruitment and signaling dynamics. These biosensors facilitate the continuous measurement ...
based inGermantown, MARYLAND (USA)
VeraChem LLC was founded in 2000 to advance the state of the art in computer-aided drug-discovery and molecular design by developing computational chemistry methods that are based on cutting edge basic science, but are also applicable in applied ...
based inNaarden, NETHERLANDS
Azafaros has leveraged on decades of discovery by professors Hans Aerts, Hermen Overkleeft, and Stan van Boeckel at Leiden University and the Academic Medical Center in the Netherlands. Expanding on their research and led by highly experienced ...
Oral administration allows for home-based, lifelong treatment, enhancing quality of life, particularly for pediatric patients, and reducing dependency on gene or enzyme replacement therapies. The U.S. FDA's Orphan Drug ...
based inPalo Alto, CALIFORNIA (USA)
Immune-Onc is a clinical-stage company developing a novel class of myeloid checkpoint inhibitors. We believe myeloid checkpoints are the next frontier of immunotherapy for cancer. In collaboration with scientists, our research team is among the ...
Immune-Onc’s lead program is IO-202, an antagonist antibody targeting the myeloid checkpoint LILRB4 (also known as ILT3). Immune-Onc has a Phase I trial underway to evaluate IO-202 as a potential treatment for acute myeloid leukemia (AML) and ...